Thomas J. Herzfeld Advisors, Inc. Amgen Inc Transaction History

Thomas J. Herzfeld Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $153,055 - $190,022	700 New	700 $188 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $3,380 - $3,869	-17 Reduced 2.37%	700 $157,000
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $3,362 - $4,126	17 Added 2.43%	717 $175,000
Q2 2017 Aug 14, 2017	BUY	N/A	700	700 $121,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Thomas J. Herzfeld Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Thomas J. Herzfeld Advisors, Inc. with notifications on news.